Nkarta (NKTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

NKTX Nkarta

Watchlist

2.590
+0.140+5.71%

Trading Nov 25 15:35 ET

182.77MMarket Cap-1415P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), Agenus (AGEN) and SAGE Therapeutics (SAGE)
TipRanksNov 25 01:10 ET · Ratings
Nkarta Price Target Lowered to $16 From $20 at Mizuho
Yahoo FinanceNov 22 06:50 ET
Nkarta Is Maintained at Outperform by Mizuho
Dow JonesNov 21 08:24 ET · Ratings
Express News | Nkarta Inc : Mizuho Cuts Target Price to $16 From $20
ReutersNov 21 06:48 ET
Here's Why We're Watching Nkarta's (NASDAQ:NKTX) Cash Burn Situation
Simply Wall StNov 18 05:41 ET
Nkarta to Participate in an Upcoming Investor Conference
GlobeNewswireNov 12 08:02 ET

Comments

iamiam

Nov 11 09:54

$Nkarta (NKTX.US)$
boom boom boom boom 💥 getting richer from my room 🤣
$Nkarta (NKTX.US)$
$Nkarta (NKTX.US)$

Unsupported feature. Please use the mobile app.

Share Your Profit/Loss

iamiam

Oct 31 00:15

$Nkarta (NKTX.US)$
I don't know why I didn't share it in my previous post or why I just thought to share it now 🤷🏽 but here we go. this is what I shared with the group.
I know i said not to buy ibrx because it was too volatile. I've changed my tune because of my biopharma outlook.... want it's twin?
cancer killing cell developer, starting with leukemia! buy rating at 17 (i think it pops to 23, but 19 is the full extension) 👌
see that daily turnaround? that's a bottom
see the accumulation at th...

Unsupported feature. Please use the mobile app.

iamiam

Oct 30 09:32

$Nkarta (NKTX.US)$
I shared this with my group. I like cancer treatment biostocks 😁
$Nkarta (NKTX.US)$

Unsupported feature. Please use the mobile app.

Share Your Profit/Loss

Goodjobguys

Aug 1 09:43

7 Cheap But Risky Biotech Stocks? Funds moving from big corporations to Small Caps?

$Immuneering (IMRX.US)$ $SPDR S&P Biotech ETF (XBI.US)$ $iShares Biotechnology ETF (IBB.US)$ $S&P 500 Index (.SPX.US)$ $BioAtla (BCAB.US)$ $Gilead Sciences (GILD.US)$ $Affimed NV (AFMD.US)$ $Instil Bio (TIL.US)$ $Nkarta (NKTX.US)$
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF XBI 0.05% drop nearly 50%.
The other most-watched exchange-traded fund that tracks the biotech secto...

Trytosaveabit

Jul 24 05:10

Update

$Nkarta (NKTX.US)$ Nkarta Has Initiated An Investigator-sponsored Trial Of NKX019, A Cd19-directed Chimeric Antigen Receptor NK-cell Therapy For Systemic Lupus Erythematosus. In June 2024, Nkarta Initiated Ntrust-1 Phase 1 Trial Of NKX019 For Lupus Nephritis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

NKTX Nkarta

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target